Moderna
MRNA
MRNA
1,104 hedge funds and large institutions have $61.9B invested in Moderna in 2021 Q4 according to their latest regulatory filings, with 221 funds opening new positions, 400 increasing their positions, 378 reducing their positions, and 232 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,104
Holders Change
-30
Holders Change %
-2.65%
% of All Funds
17.05%
Holding in Top 10
22
Holding in Top 10 Change
-17
Holding in Top 10 Change %
-43.59%
% of All Funds
0.34%
New
221
Increased
400
Reduced
378
Closed
232
Calls
$5.69B
Puts
$7.59B
Net Calls
-$1.9B
Net Calls Change
-$599M
Top Buyers
| 1 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
$11.6B |
| 2 |
Barclays
London,
United Kingdom
|
$839M |
| 3 |
TP
Theleme Partners
London,
United Kingdom
|
$1.28B |
| 4 |
Invesco
Atlanta,
Georgia
|
$446M |
| 5 |
State Street
Boston,
Massachusetts
|
$3.77B |
Top Sellers
| 1 |
LPC
Lone Pine Capital
Greenwich,
Connecticut
|
$0 |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
$1.07B |
| 3 |
Coatue Management
New York
|
$1.09B |
| 4 |
Morgan Stanley
New York
|
$1.23B |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
$826K |